The unfinished measles immunization agenda

Journal of Infectious Diseases

Volumn 187, Issue SUPPL. 1, 2003, Pages

  Strebel, Peter ^a   Cochi, Stephen ^a   Grabowsky, Mark ^b   Bilous, Julian ^c   Hersh, Bradley S ^c   Okwo Bele, Jean Marie ^d   Hoekstra, Edward ^d   Wright, Peter ^e   Katz, Samuel ^f  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b American Red Cross   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d UNITED NATIONS   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE;

CAUSE OF DEATH; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN RIGHTS; INFECTION CONTROL; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; MEDICAL RESEARCH; MORTALITY; POLITICS; PRIORITY JOURNAL; REVIEW; UNITED NATIONS; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; MEASLES; MEASLES VACCINE; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 0038580978     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/368226     Document Type: Review

References (53)

1. Stein CE, Birmingham M, Kurian M, Duclos P, Strebel P. The global burden of measles in the year 2000 - a model that uses country-specific indicators. J Infect Dis 2003; 187(Suppl 1):S8-14 (in this issue).
2. Henao-Restrepo A-M, Strebel P, Hoekstra EJ, Birmingham M, Bilous J. Experience in global measles control, 1990-2001. J Infect Dis 2003; 187(Suppl 1):S15-21 (in this issue).
3. Carabin H, Edmunds WJ. Future savings from measles eradication in industrialized countries. J Infect Dis 2003; 187(Suppl 1):S29-35 (in this issue).
4. Otten MW Jr, Okwo-Bele J-M, Kezaala R, Biellik R, Eggers R, Nshimirimana D. Impact of alternative approaches to accelerated measles control: experience in the African Region, 1996-2002. J Infect Dis 2003; 187(Suppl 1):S36-43 (in this issue).
5. de Quadros CA, Izurieta H, Carrasco P, Brana M, Tambini G. Progress toward measles eradication in the Region of the Americas. J Infect Dis 2003; 187(Suppl 1):S102-10 (in this issue).
6. Gaafar T, Moshni E, Lievano F. The challenge of achieving measles elimination in the Eastern Mediterranean Region by 2010. J Infect Dis 2003; 187(Suppl 1):S164-71 (in this issue).
7. Garbouj M, Slim A, Ben Ghorbal M, et al. Progress toward interruption of endemic measles transmission in Tunisia. J Infect Dis 2003; 187(Suppl 1):S172-6 (in this issue).
8. Dadgar N, Ansari A, Naleo T, et al. Implementation of a mass measles campaign in central Afghanistan, December 2001 to May 2002. J Infect Dis 2003; 187(Suppl 1):S186-90 (in this issue).
9. Spika JS, Wassilak S, Pebody R, et al. Measles and rubella in the World Health Organization European Region: diversity creates challenges. J Infect Dis 2003; 187(Suppl 1):S191-7 (in this issue).
10. Hellenbrand W, Siedler A, Tischer A, et al. Progress toward measles elimination in Germany. J Infect Dis 2003; 187(Suppl 1):S208-16 (in this issue).
11. Gürişs D, Bayazit Y, Özdemirer Ü, et al. Measles epidemiology and elimination strategies in Turkey. J Infect Dis 2003; 187(Suppl 1):S230-4 (in this issue).
12. Ramsay ME, Jin L, White J, Litton P, Cohen B, Brown D. The elimination of indigenous measles transmission in England and Wales. J Infect Dis 2003; 187(Suppl 1):S198-207 (in this issue).
13. Pistol A, Hennessy K, Pitigoi D, et al. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance. J Infect Dis 2003; 187(Suppl 1):S217-22 (in this issue).
14. Bino S, Kakarriqi E, Xibinaku M, et al. Measles-rubella mass immunization campaign in Albania, November 2000. J Infect Dis 2003; 187(Suppl 1):S223-9 (in this issue).
15. Puvimanasinghe JPA, Arambepola CK, Abeysinghe NMR, Rajapaska LC, Kulatilaka TA. Measles outbreak in Sri Lanka, 1999-2000. J Infect Dis 2003; 187(Suppl 1):S241-5 (in this issue).
16. Lixia W, Guang Z, Lee LA, et al. Progress in accelerated measles control in the People's Republic of China, 1991-2000. J Infect Dis 2003; 187(Suppl 1):S252-7 (in this issue).
17. McFarland JW, Mansoor OD, Yang B. Accelerated measles control in the Western Pacific Region. J Infect Dis 2003; 187(Suppl 1):S246-51 (in this issue).
18. Pless RP, Bentsi-Enchill AD, Duclos P. Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues. J Infect Dis 2003; 187(Suppl 1):S291-8 (in this issue).
19. Hersh BS, Carr RM, Fitzner J, et al. Ensuring injection safety during measles mass immunization campaigns: more than auto-disable syringes and safety boxes. J Infect Dis 2003; 187(Suppl 1):S299-306 (in this issue).
20. Bellini WJ, Helfand RF. The challenges and strategies for laboratory diagnosis of measles in an international setting. J Infect Dis 2003; 187(Suppl 1):S283-90 (in this issue).
21. Featherstone D, Brown D, Sanders R. Development of the global measles laboratory network. J Infect Dis 2003; 187(Suppl 1):S264-9 (in this issue).
22. Rota PA, Bellini WJ. Update on the global distribution of genotypes of wild type measles viruses. J Infect Dis 2003; 187(Suppl 1):S270-6 (in this issue).
23. Murray CJL, Lopez AD, Mathers CD, Stein C. The global burden of disease 2000 project: aims, methods, and data sources. Global Programme on Evidence for Health Policy. Discussion paper 36. Geneva: WHO, 2001; 11:10-49.
24. World Health Organization. Global measles mortality reduction and regional elimination, 2000-2001. Part I. Wkly Epidemiol Rec 2002; 77:50-5. Available at: http://www.who.int/wer/pdf/2002/wer7707.pdf.
25. Assefa F, Jabarkhil MZ, Salama P, Spiegel P. Malnutrition and mortality in Kohistan District, Afghanistan, April 2001. JAMA 2001; 286:2723-8.
26. Kamugisha C, Cairns KL, Akim C. An outbreak of measles in Tanzanian refugee camps. J Infect Dis 2003; 187(Suppl 1):S58-62 (in this issue).
27. Aiqiang X, Zijian F, Wenbo X, et al. Active case-based surveillance for measles in China: lessons learned from Shangdong and Henan provinces. J Infect Dis 2003; 187(Suppl 1):S258-63 (in this issue).
28. Hersh BS, Tambini G, Noguiera AC, Carrasco P, de Quadros CA. Review of regional measles surveillance data in the Americas, 1996-99. Lancet 2000; 355:1943-8.
29. Biellik R, Madema S, Taole A, et al. First 5 years of measles elimination in southern Africa: 1996-2000. Lancet 2002; 359:1564-8.
30. Munyoro MN, Kufa E, Biellik R, Pazvakavambwa IE, Cairns KL. Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001. J Infect Dis 2003; 187(Suppl 1):S91-6 (in this issue).
31. Duclos P, Ward BJ. Measles vaccines: a review of adverse events. Drug Saf 1998; 19:435-54.
32. Venczel L, Dobbins J, Andre J, et al. Measles eradication in the Americas: experience in Haiti. J Infect Dis 2003; 187(Suppl 1):S127-32 (in this issue).
33. Bosu WK, Essel-Ahun M, Adjei S, Strebel P. Progress in the control of measles in Ghana, 1980-2000. J Infect Dis 2003; 187(Suppl 1):S44-50 (in this issue).
34. Cliff J, Simango A, Augusto O, Van der Paal L, Biellik R. Failure of targeted supplemental measles vaccination campaigns (1997-1999) to prevent measles epidemics in Mozambique (1998-2001). J Infect Dis 2003; 187(Suppl 1):S51-7 (in this issue).
35. Yaméogo KR, Yaméogo A, Nacoulma SD, Zuber PLF. Measles vaccination coverage during poliomyelitis National Immunization Days in Burkina Faso, 1999. J Infect Dis 2003; 187(Suppl 1):S74-9 (in this issue).
36. World Health Organization and United Nations Children's Fund. Measles mortality reduction and regional elimination: strategic plan, 2001-2005. Geneva: WHO, 2001 (WHO/V&B/01.13).
37. Ramsay M. A strategic framework for the elimination of measles in the European Region. Copenhagen: WHO Regional Office for Europe, 1999 (EUR/ICP/CMDS 01 01 05).
38. United Nations. A world fit for children. United Nations Special Session on Children (8-10 May 2002). Available (page 14) at: http://www.unicef.org/specialsession/docs_new/documents/A-RES-S27 -2E.pdf.
39. Prevots DR, Parise MS, Segatto TCV, et al. Interruption of measles transmission in Brazil, 2000-2001. J Infect Dis 2003; 187(Suppl 1):S111-20 (in this issue).
40. Centers for Disease Control and Prevention. Measles - United States, 2000. MMWR Morb Mortal Wkly Rep 2002; 51:120-3.
41. Hutchins SS, Redd SC, Schrag S, et al. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994. MedGenMed 2001; 24 January:E5.
42. Anderson RM, May RM. Vaccination and herd immunity to infectious diseases. Nature 1985; 318:323-9.
43. United Nations. The international covenant on economic, social and cultural rights. New York: UN, 1966.
44. De Serres G, Gay NJ, Farrington CP. Epidemiology of transmissible diseases after elimination. Am J Epidemiol 2000; 151:1039-48.
45. de Quadros CA, Olive JM, Hersh BS, et al. Measles elimination in the Americas: evolving strategies. JAMA 1996; 275:224-9.
46. Izurieta H, Venzcel L, Dietz V, et al. Monitoring measles eradication in the Region of the Americas: critical activities and tools. J Infect Dis 2003; 187(Suppl 1):S133-9 (in this issue).
47. Cochi SL, Hull HF, Sutter RW, Wilfert CM, Katz SL. Commentary: the unfolding story of global poliomyelitis eradication. J Infect Dis 1997; 175(Suppl 1):S1-3.
48. Grabowsky M, Strebel P, Gay A, Hoekstra E, Kezaala R. Measles elimination in southern Africa [letter]. Lancet 2002; 360:716.
49. Centers for Disease Control and Prevention. Outbreak of measles - Venezuela and Colombia. MMWR Morb Mortal Wkly Rep 2002; 51:757-60.
50. Costa A, Henao-Restrepo A-M, Hall SM, Jarrett S, Hoekstra EJ. Determining measles-containing vaccine demand and supply: an imperative to support measles mortality reduction efforts. J Infect Dis 2003; 187(Suppl 1):S22-8 (in this issue).
51. United Nations Children's Fund. Vaccine security: ensuring a sustained, uninterrupted supply of affordable vaccines. New York: UN, 2001 (E/ICEF/2002/6).
52. World Health Organization. Report of a meeting on research related to measles control and elimination, 27-29 March 2000, Geneva: WHO, 2000 (WHO/V&B/00.31).
53. The Bill and Melinda Gates Foundation. Available at: http://www.gatesfoundation.org/globalhealth/infectiousdiseases/ grants/default.asp?showYear=2002.